VERU (Veru Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by VERU officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-17 | K GARY BARNETTE | Chief Scientific Officer | Buy | — | — |
| 2026-05-06 | Loren Mark Katzovitz | Director | A | — | — |
| 2026-05-06 | Lucy Lu | Director | A | — | — |
| 2026-05-06 | Grace Hyun | Director | A | — | — |
| 2026-05-06 | HARRY FISCH | Chief Corporate Officer | A | — | — |
| 2026-05-06 | Michele Greco | Chief Admin Officer and CFO | A | — | — |
| 2026-05-06 | MITCHELL SHUSTER STEINER | President and CEO | A | — | — |
| 2026-05-06 | K GARY BARNETTE | Chief Scientific Officer | A | — | — |
| 2026-05-06 | Michael L Rankowitz | Director | A | — | — |
| 2025-12-09 | MITCHELL SHUSTER STEINER | President and CEO | A | — | — |
| 2025-12-09 | Michael L Rankowitz | Director | A | — | — |
| 2025-12-09 | HARRY FISCH | Chief Corporate Officer | A | — | — |
| 2025-12-09 | Michele Greco | Chief Admin Officer and CFO | A | — | — |
| 2025-12-09 | Lucy Lu | Director | A | — | — |
| 2025-12-09 | K GARY BARNETTE | Chief Scientific Officer | A | — | — |
| 2025-12-09 | Grace Hyun | Director | A | — | — |
| 2025-12-09 | Loren Mark Katzovitz | Director | A | — | — |
| 2025-10-03 | Lucy Lu | Director | A | — | — |
| 2025-10-03 | Michael L Rankowitz | Director | A | — | — |
| 2025-10-03 | Grace Hyun | Director | A | — | — |
| 2025-05-08 | Loren Mark Katzovitz | Director | A | — | — |
| 2025-05-08 | K GARY BARNETTE | Chief Scientific Officer | A | — | — |
| 2025-05-08 | Michele Greco | Chief Admin Officer and CFO | A | — | — |
| 2025-05-08 | MITCHELL SHUSTER STEINER | President and CEO | A | — | — |
| 2025-05-08 | Michael L Rankowitz | Director | A | — | — |
| 2025-05-08 | HARRY FISCH | Chief Corporate Officer | A | — | — |
| 2025-05-08 | Grace Hyun | Director | A | — | — |
| 2025-05-08 | Lucy Lu | Director | A | — | — |
| 2025-03-14 | Grace Hyun | Director | A | — | — |
| 2025-03-14 | Loren Mark Katzovitz | Director | A | — | — |
| 2025-02-20 | Michael L Rankowitz | Director | Buy | — | — |
| 2024-10-02 | Grace Hyun | Director | A | — | — |
| 2024-10-02 | Michael L Rankowitz | Director | A | — | — |
| 2024-10-02 | Mario Eisenberger | Director | A | — | — |
| 2024-10-02 | Lucy Lu | Director | A | — | — |
| 2024-08-07 | Loren Mark Katzovitz | Director | A | — | — |
| 2024-08-07 | Lucy Lu | Director | A | — | — |
| 2024-08-07 | Mario Eisenberger | Director | A | — | — |
| 2024-08-07 | Grace Hyun | Director | A | — | — |
| 2024-08-07 | Michael L Rankowitz | Director | A | — | — |
| 2024-05-28 | HARRY FISCH | Chief Corporate Officer | Buy | — | — |
| 2024-05-24 | K GARY BARNETTE | Chief Scientific Officer | Buy | — | — |
| 2024-05-24 | MITCHELL SHUSTER STEINER | President and CEO | Sell | — | — |
| 2024-05-17 | MITCHELL SHUSTER STEINER | President and CEO | Sell | — | — |
| 2024-05-17 | HARRY FISCH | Chief Corporate Officer | Buy | — | — |
| 2024-05-09 | MITCHELL SHUSTER STEINER | President and CEO | A | — | — |
| 2024-05-09 | HARRY FISCH | Chief Corporate Officer | A | — | — |
| 2024-05-09 | Michele Greco | Chief Admin Officer and CFO | A | — | — |
| 2024-05-09 | K GARY BARNETTE | Chief Scientific Officer | A | — | — |
| 2023-11-17 | Grace Hyun | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Corporate Officer | 801,384 | — |
| — | President and CEO | 715,039 | — |
| — | Director | 103,135 | — |
| — | Director | 57,598 | — |
| — | Director | 25,000 | — |
| — | Chief Admin Officer and CFO | 9,618 | — |
| — | Director | 5,500 | — |
| — | Director | 3,250 | — |
| — | Chief Scientific Officer | 2,300 | — |
| — | Director | 1,479 | — |
| — | Director | 980 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VERU quote page; the site-wide leaderboard is on the insider transactions hub.